血液透析病人高磷血症的治疗进展(4)
6. Slaopolsky E,Delmez JA. Pathogenesis of secondary hyperparathyroidism.Am J Kidney Dis 1994;23:229-236.
7. Almader Y, Canalejo A, Hernandez A, et al. Direct effect of phosphorus on PTH secretion rom whole rat parathyroid glands in vitro. J Bone Miner Res 1996;11:970-976.
8. Gimenez LF, Solez K, Walker WG. Relation between renal calcium content and renal impairment in 246humn renal biopsies. Kidney Int 1987;31:93-99.
, 百拇医药
9. Sanders C, Frand MS, Rostand SG, Rutsky EA, Barmes GT, fraser RG; metastatic calification of the heart and lungs in end-stage renal disease: Detection and quantification by dual-energy digital chest radiography. Am J Roentgenol 1987;149:881-887.
10. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996;27:394-401.
, 百拇医药
11. Massry SG. Divaent Ion Metabolism and Renal Osteodystrophy. In:Massry's and Glassoch's Texbook of Nephrology (3rd Ed), Massry SG, Glassock RJ (eds). Baltimore: Williams &Wilkins, ppl,441-1,473 1995.
12. Llach F. Calcifif uremic arteriolopathy (calciphylaxis): An Evolving entity? Am J Kidney Dis 1998; 32:514-518.
13. Hercz G, Clburn JW. Prevenion of phosphate retention and hyperphosphatemia in ruemia. Kidney Int, 1987;32(Sup;22):S215
, http://www.100md.com
14. Emmet M, Sirmon MD, Kirkoatrich WG et al. Calcium acetate control of serum phosphorus in hemodialysis patients. Am J Kidney Bis, 1991;17(5):544
15. Mai ML, Emmett M, Sheikh MS, schiller L, Fordtran JS. Calcium acetate, an effective phosphorus binder in patients with renal failure. Kidney Int 1989 36:690695.
16. Ritz E, Hergesell O. Oral phosphate binders without aluninum and calcium:Apipe-dream? Nephrol Dial Transp; 1996;11:766-768.
, 百拇医药
17. Sperschneider H, Gunther K, Marzoll I, Krichner e, Stein G.Calcum carbonate (CaCO3): An efficient and safe phosphate binder in haemodialysis patinents? A 3-year study. Nephrol Dial Transpl 1993;8:530-534.
18. Emmett M, sirmon MD, Kirkpatrick WG, Nolan CR, Schmitt GW, Cleveland MB. Calcium acetate control of serum phophorus in hemodialysis patients./ am J Kidney Dis 1991;17:544-550.
19. Hamida FB, Esper IE, Compagnon M et al. Long-term (6 moths) crossover comparison of calcium acetate with calcium carbonate as phosphate binder. Nephron, 1993;63:258
20. Norris KC. Determining the appropriate dosage of Calcijex (calcitriolinjection) for Hemodialysis patients with secondary hyperparathyroidism. Neph Exchange 1996;6:5-11., http://www.100md.com(王世相综述 管德林审校相综述 管德林审校)
7. Almader Y, Canalejo A, Hernandez A, et al. Direct effect of phosphorus on PTH secretion rom whole rat parathyroid glands in vitro. J Bone Miner Res 1996;11:970-976.
8. Gimenez LF, Solez K, Walker WG. Relation between renal calcium content and renal impairment in 246humn renal biopsies. Kidney Int 1987;31:93-99.
, 百拇医药
9. Sanders C, Frand MS, Rostand SG, Rutsky EA, Barmes GT, fraser RG; metastatic calification of the heart and lungs in end-stage renal disease: Detection and quantification by dual-energy digital chest radiography. Am J Roentgenol 1987;149:881-887.
10. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996;27:394-401.
, 百拇医药
11. Massry SG. Divaent Ion Metabolism and Renal Osteodystrophy. In:Massry's and Glassoch's Texbook of Nephrology (3rd Ed), Massry SG, Glassock RJ (eds). Baltimore: Williams &Wilkins, ppl,441-1,473 1995.
12. Llach F. Calcifif uremic arteriolopathy (calciphylaxis): An Evolving entity? Am J Kidney Dis 1998; 32:514-518.
13. Hercz G, Clburn JW. Prevenion of phosphate retention and hyperphosphatemia in ruemia. Kidney Int, 1987;32(Sup;22):S215
, http://www.100md.com
14. Emmet M, Sirmon MD, Kirkoatrich WG et al. Calcium acetate control of serum phosphorus in hemodialysis patients. Am J Kidney Bis, 1991;17(5):544
15. Mai ML, Emmett M, Sheikh MS, schiller L, Fordtran JS. Calcium acetate, an effective phosphorus binder in patients with renal failure. Kidney Int 1989 36:690695.
16. Ritz E, Hergesell O. Oral phosphate binders without aluninum and calcium:Apipe-dream? Nephrol Dial Transp; 1996;11:766-768.
, 百拇医药
17. Sperschneider H, Gunther K, Marzoll I, Krichner e, Stein G.Calcum carbonate (CaCO3): An efficient and safe phosphate binder in haemodialysis patinents? A 3-year study. Nephrol Dial Transpl 1993;8:530-534.
18. Emmett M, sirmon MD, Kirkpatrick WG, Nolan CR, Schmitt GW, Cleveland MB. Calcium acetate control of serum phophorus in hemodialysis patients./ am J Kidney Dis 1991;17:544-550.
19. Hamida FB, Esper IE, Compagnon M et al. Long-term (6 moths) crossover comparison of calcium acetate with calcium carbonate as phosphate binder. Nephron, 1993;63:258
20. Norris KC. Determining the appropriate dosage of Calcijex (calcitriolinjection) for Hemodialysis patients with secondary hyperparathyroidism. Neph Exchange 1996;6:5-11., http://www.100md.com(王世相综述 管德林审校相综述 管德林审校)